|
TH1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.466000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.023600E-01 |
| Normal-vs-Stage2 |
5.570600E-01 |
| Normal-vs-Stage3 |
2.598200E-01 |
| Normal-vs-Stage4 |
4.643800E-01 |
| Stage1-vs-Stage2 |
5.344800E-01 |
| Stage1-vs-Stage3 |
2.633400E-01 |
| Stage1-vs-Stage4 |
5.037400E-01 |
| Stage2-vs-Stage3 |
2.253800E-01 |
| Stage2-vs-Stage4 |
8.442800E-01 |
| Stage3-vs-Stage4 |
2.633400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.267200E-01 |
| Normal-vs-AfricanAmerican |
6.927000E-01 |
| Normal-vs-Asian |
8.325600E-01 |
| Caucasian-vs-AfricanAmerican |
2.381800E-01 |
| Caucasian-vs-Asian |
7.149000E-01 |
| AfricanAmerican-vs-Asian |
9.780800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.663800E-01 |
| Normal-vs-Female |
3.408200E-02 |
| Male-vs-Female |
3.420100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.243400E-01 |
| Normal-vs-Extreme_Weight |
4.658400E-01 |
| Normal-vs-Obese |
1.794370E-01 |
| Normal-vs-Extreme_Obese |
4.770800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.830200E-01 |
| Normal_Weight-vs-Obese |
3.012000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.107600E-01 |
| Extreme_Weight-vs-Obese |
1.099980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.056400E-01 |
| Obese-vs-Extreme_Obese |
2.810000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.778800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.394100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.860600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.736300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.505400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.346200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.140380E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.373810E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.632600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.370100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.877800E-02 |
| Normal-VS-Type2 PRCC |
1.061870E-02 |
| Normal-VS-KIRP CIMP |
8.742000E-01 |
| Normal-VS-Unclassified PRCC |
1.031780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.558700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.891600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.986800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.948800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.090090E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.391600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.052400E-01 |
| Normal-vs-N1 |
5.090000E-01 |
| Normal-vs-N2 |
2.864600E-01 |
| N0-vs-N1 |
2.794400E-01 |
| N0-vs-N2 |
4.970200E-01 |
| N1-vs-N2 |
2.767600E-01 |
|
|
